Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain functional signature of connected consciousness under general anesthesia
2019-002848-24Phase 2Completed
- Sponsor
- GIGA-Consciousness
- Start
- Jan 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of propofol, remifentanil, rocuronium and Sugammadex (3 arms), sponsored by GIGA-Consciousness. Started Jan 2020; status: completed.
02
Drugs
propofolremifentanilrocuroniumSugammadex
Beyond the preview
Go deeper on 2019-002848-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002848-24.